Drug
Cilofexor Dose B
Cilofexor Dose B: highest development phase Phase 2, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cilofexor Dose B NCT07841977 | Phase 2 | Primary Biliary Cholangitis |
Latest
No recent events.
Follow Cilofexor Dose B on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.